These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 22385832

  • 41. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A.
    Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
    [Abstract] [Full Text] [Related]

  • 42. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
    Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JB, Szafranski W, Vestbo J.
    Thorax; 2005 Dec; 60(12):992-7. PubMed ID: 16227327
    [Abstract] [Full Text] [Related]

  • 43. Weaning from inhaled corticosteroids in COPD: the evidence.
    Suissa S, Rossi A.
    Eur Respir J; 2015 Nov; 46(5):1232-5. PubMed ID: 26521271
    [No Abstract] [Full Text] [Related]

  • 44. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 45. Inhaled corticosteroids and mortality in COPD.
    Omron E.
    Chest; 2007 Mar; 131(3):939; author reply 940. PubMed ID: 17380589
    [No Abstract] [Full Text] [Related]

  • 46. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD, Man SF.
    Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
    [Abstract] [Full Text] [Related]

  • 47. A rare case of adrenal insufficiency induced by inhaled corticosteroids.
    Samaras N, Schneider A, Frangos E, Forster A, Samaras D.
    J Am Geriatr Soc; 2013 May; 61(5):841-2. PubMed ID: 23672559
    [No Abstract] [Full Text] [Related]

  • 48. Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?
    Burgel PR, Deslée G, Jebrak G, Brinchault G, Caillaud D, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Paillasseur JL, Perez T, Roche N, Initiatives BPCO scientific committee.
    Eur Respir J; 2014 Apr; 43(4):1201-3. PubMed ID: 24176996
    [No Abstract] [Full Text] [Related]

  • 49. Current perspectives on the contribution of inhaled corticosteroids to an increased risk for diabetes onset and progression in patients with chronic obstructive pulmonary disease.
    Herth FJ, Bramlage P, Müller-Wieland D.
    Respiration; 2015 Apr; 89(1):66-75. PubMed ID: 25471093
    [Abstract] [Full Text] [Related]

  • 50. COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
    Saha S, Siva R, Brightling CE, Pavord ID.
    Eur Respir J; 2006 Apr; 27(4):863-5. PubMed ID: 16585097
    [No Abstract] [Full Text] [Related]

  • 51. Inhaled corticosteroids in COPD and the risk of pneumonia.
    Welte T.
    Lancet; 2009 Aug 29; 374(9691):668-70. PubMed ID: 19716946
    [No Abstract] [Full Text] [Related]

  • 52. Some inhaled corticosteroids for COPD.
    Med Lett Drugs Ther; 2017 Apr 10; 59(1518):e66-e666. PubMed ID: 28377553
    [No Abstract] [Full Text] [Related]

  • 53. [Risk of pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids: evidence and uncertainties].
    Incorvaia C, Gritti B, Martignago I, Riario-Sforza GG, Ridolo E.
    Ig Sanita Pubbl; 2016 Apr 10; 72(6):583-588. PubMed ID: 28214911
    [Abstract] [Full Text] [Related]

  • 54. Inhaled corticosteroids and mortality in COPD.
    Netzer G.
    Chest; 2007 Mar 10; 131(3):939; author reply 940. PubMed ID: 17356119
    [No Abstract] [Full Text] [Related]

  • 55. Five questions in chronic obstructive pulmonary disease.
    Miravitlles M.
    Expert Rev Respir Med; 2013 Apr 10; 7(2 Suppl):1-2. PubMed ID: 23551018
    [No Abstract] [Full Text] [Related]

  • 56. Inhaled corticosteroids should not be prescribed to all chronic obstructive pulmonary disease patients.
    Bourbeau J, McIvor A.
    Can Respir J; 2003 Apr 10; 10(3):148-9. PubMed ID: 12712224
    [No Abstract] [Full Text] [Related]

  • 57. An update on the use of inhaled therapy in COPD.
    Price O, Sarkar C, Konda S.
    Clin Med (Lond); 2018 Oct 10; 18(5):387-390. PubMed ID: 30287432
    [Abstract] [Full Text] [Related]

  • 58. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts.
    Ernst P, Baltzan M, Deschênes J, Suissa S.
    Eur Respir J; 2006 Jun 10; 27(6):1168-74. PubMed ID: 16481387
    [Abstract] [Full Text] [Related]

  • 59. Use of inhaled corticosteroids for obstructive lung disease following anti-tuberculosis treatment.
    Harries AD, Ade S, Hoa NB, Satyanarayana S, Kumar AMV.
    Int J Tuberc Lung Dis; 2017 Jul 01; 21(7):833-834. PubMed ID: 28633712
    [No Abstract] [Full Text] [Related]

  • 60. Stopping inhaling corticosteroids in COPD.
    Pesola GR, Dogra S.
    Am J Respir Crit Care Med; 2003 Jul 15; 168(2):256-7; author reply 257. PubMed ID: 12851248
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.